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Abstract 48 
Tularemia caused by Francisella tularensis is a zoonotic infection of the Northern 49 
Hemisphere that mainly affects skin, lymph nodes, bloodstream and lungs. Other 50 
manifestations of tularemia are very rare, especially with musculoskeletal 51 
involvement. Presenting in 2016, we diagnosed two cases of periprosthetic knee joint 52 
infections (PJI) caused by Francisella tularensis in Europe (one in Switzerland, one in 53 
Czech Republic). We only found two other PJI cases in literature, another knee PJI 54 
diagnosed 1999 in Ontario, Canada, and one hip PJI in Illinois, USA 2017. Diagnosis 55 
was made in all cases by positive microbiological cultures after 3, 4, 7, and 12 days. 56 
All were successfully treated, two cases with exchange of the prosthesis, one with 57 
debridement and retention, and one with repeated aspiration of the synovial fluid 58 
only. Antibiotic treatment was given between 3 weeks and 12 months wither either 59 
ciprofloxacin/rifampin or with doxycycline alone or doxycycline in combination with 60 
gentamicin.  61 
Zoonotic infections should be considered in periprosthetic infections in particular in 62 
culture negative PJIs with a positive histology or highly elevated leucocytes in 63 
synovial aspiration. Here we recommend to prolong cultivation time up to 14 days, 64 
perform specific PCR tests, and/or do epidemiologically appropriate serological tests 65 
for zoonotic infections including that for F. tularensis.  66 
 67 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
P4 
 
Introduction 68 
Most commonly isolated microorganisms in periprosthetic joint infections (PJIs) are 69 
staphylococci, streptococci, enterococci, Gram-negative rods, and anaerobic bacteria 70 
(1). However, 5-35% of PJI remain culture negative (1) either because of antibiotics 71 
given prior to diagnostic aspiration, the inability to detect a recognized PJI pathogen 72 
using currently available diagnostic methods, or because of difficulty to cultivate or 73 
otherwise identify fastidious microorganisms such as anaerobes, mycobacteria, or 74 
fungi.  75 
Little is known about zoonotic infections in joint replacements. We report two PJI 76 
cases caused by Francisella tularensis diagnosed in Europe. We searched for 77 
positive cultures and specific serology for F. tularensis in our microbiological 78 
database in general and reviewed literature of other orthopedic infections caused by 79 
F. tularensis. Focusing on PJIs, we summarized their clinical and microbiological 80 
characteristics in a mini-review.  81 
 82 
Methods 83 
Culture and identification methods 84 
University of Zurich: To extract bacteria from periprosthetic tissue, samples were 85 
vortexed using 4mm glass beads (Sarstedt, Nürmbrecht, Germany). After 86 
homogenization, samples were incubated under aerobic and anaerobic conditions on 87 
agar plates and in thioglycolate broth (BD, Allschwil, Switzerland) for enrichment. For 88 
aerobic cultivation Columbia sheep blood agar without antibiotics (BioMérieux, Mary-89 
l’Etoile, France), Colistin nalidixin acid (CNA) blood agar (BioMérieux), MacConkey 90 
agar (BioMérieux), and Crowe agar (chocolate agar supplemented with bacitracin 91 
and isovitalex (Difco GC medium, Becton Dickinson)) were used. Brucella agar 92 
(anaerobic sheep blood agar plates with haemin and vitamin K1, BioMérieux), 93 
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kanamycin-vancomycin agar (laked sheep blood brucella agar plates with kanamycin 94 
and vancomycin, BD), and phenylethylalcohol agar plates (BD) were used for 95 
anaerobic cultivation (Whitley anaerobic workstation MG1000, Don Whitley Scientific, 96 
West Yorkshire, England). Agar plates were incubated for 7 days at 37 °C. 97 
Thioglycolate broth medium was inspected daily for cloudiness, then subsequently 98 
plated onto chocolate (aerob) and Brucella (anaerob) agar plates for further 99 
identification. If thioglycolate broth cultures were negative after 10 days of cultivation, 100 
blind subcultures plated on chocolate and Brucella agar plates were performed and 101 
cultivated for another 2-3 days. Any suspicious bacterial colony, will be analyzed by 102 
matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-103 
TOF MS) using a Bruker MALDI Biotyper in combination with research-use-only 104 
(RUO) versions of the MALDI Biotyper software package (version 3.0) and the 105 
reference database V.3.3.1.0 (4613 entries) or later database versions.  106 
Ceske Budejovice Hospital: Cultivation methods and duration of cultivations were 107 
done in a similar way than in Zurich.  108 
 109 
Retrospective case finding 110 
We searched for published PJI cases caused by F. tularensis using PubMed, 111 
Scopus, and Medline for an epidemiological investigation (searched keywords: 112 
Francisella, tular*, joint, arthritis, prosth*, osteomyelitis, bone, replacement).  113 
Retrospective microbiological review 114 
We reviewed our hospital databases at the Institute for Clinical Microbiology at the 115 
University of Zurich and the Ceske Budejovice Hospital for positive F. tularensis 116 
serology or cultures with association of bone and joint infection.  117 
 118 
  119 
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Results 120 
Two cases in Europe in 2016 121 
Case 1. An 84-year-old Swiss woman presented in July 2015 with chronic knee pain 122 
with reported onset since December 2014 after a right knee joint arthroplasty in 2002. 123 
Intermittently, she observed an erythema above the knee without swelling. Serum C-124 
reactive protein (CRP) was elevated with 64 mg/L. Synovial aspiration of the right 125 
knee joint revealed elevated leucocytes of 11,850 cells/µL with dominance of 126 
neutrophils (80%) without any growth of microorganisms. X-ray showed no loosening 127 
of the implant but small tibial osteolysis. A PJI was suspected and the prosthesis was 128 
removed as the first surgery of a two-stage exchange of the prosthesis. At time of 129 
explantation of the prosthesis, five out of six tissue biopsies showed growth of F. 130 
tularensis on a blind subculture on day 12 after a blind subculture of thioglycolate 131 
broth inoculated on day 10, while inoculation on agar plates remained negative. 132 
Histology of a tissue biopsy of the recessus medialis revealed focal acute 133 
inflammation (dominance of neutrophils) and extended wear of the prosthesis 134 
(Supplemental Figure 1a and 1 b). Serology with elevated IgM and IgG was in line 135 
with a F. tularensis infection. We changed the empiric intravenous antibiotic 136 
treatment with amoxicillin-clavulanate to oral doxycycline for a total duration of six 137 
weeks after implant removal. After two weeks off antibiotics, the new knee prosthesis 138 
was successfully implanted. In the last follow-up two years later, the patient was 139 
feeling well and having a good quality of life, free of infection and a follow-up 140 
tularemia IgM titer went down from 232 to 111 (U/ml). As a potential acquisition of F. 141 
tularensis we thought of airborne transmission of contaminated dust while cleaning 142 
the near located rabbit barn, or a tick bite. However, the patient could not remember 143 
any tick bite. She remembered having an episode of fever and sore throats a few 144 
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months before the onset of knee pain. None of the 10 laboratory staff involved in 145 
handling the culture-positive agar plates showed a seroconversion after two months. 146 
 147 
Case 2. An 84-year-old Czech male had a history of right knee total arthroplasty in 148 
2006 and PJI in the same joint caused by Escherichia coli in 2008 that was treated 149 
with open synovectomy, mobile components replacement and retention of the fixed 150 
components, along with antibiotic therapy. After this, he was asymptomatic for 8 151 
years. 152 
In July 2016, he presented with fever, abdominal pain and elevated inflammatory 153 
parameters (CRP 166mg/L), but no source of infection was found. He was treated 154 
with oral amoxicillin-clavulanate and discharged as fever and abdominal symptoms 155 
rapidly resolved. Ten days later, he presented to an orthopedic clinic complaining of 156 
increasing pain in the right knee where a large effusion had developed. Blood tests 157 
have shown leucocyte count of 4.80×109cells/mL and CRP 98.4mg/L. The right knee 158 
effusion was aspirated yielding over 70 mL of cloudy fluid, which showed highly 159 
elevated leukocytes (++++ by microscopy, flow cytometry was not possible because 160 
of high viscosity of the fluid) and no organisms. After four days of the aspirate 161 
incubation, small colonies of Gram-labile (indifferent state) to Gram-negative 162 
coccobacilli were seen on Columbia 5% sheep blood agar (Bio-Rad Corp., Hercules, 163 
CA, USA). Because of their morphological appearance, F. tularensis was suspected 164 
and 16S rDNA sequencing was performed from the colonies, which confirmed the 165 
identification. Serology for tularemia had shown a 1:80 titer (total antibody; 166 
microagglutination test, Bioveta Inc, Ivanovice na Hané, Czech Republic).  167 
 The knee X-ray was not suggestive of loosening of the implant and a 168 
synovectomy and mobile components replacement with retention of the joint 169 
prosthesis was recommended. The patient declined any surgical intervention, and 170 
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therefore he was treated with doxycycline 100 mg orally twice a day for 21 days, of 171 
which the first 10 days in combination with gentamicin 240 mg intravenously once 172 
daily. Two months later he presented with recurring effusion of the knee, and the 173 
second re-aspiration has shown fluid with minimum white cells, no bacterial growth of 174 
prolonged culture and negative 16S rDNA PCR. He was given another course of 175 
antibiotics, this time ciprofloxacin 500 mg orally twice a day for 20 days.  176 
During the follow up, the persistent small, pain-free effusion in his right knee was re-177 
aspirated after four, 10, and 24 months from the initial presentation. All aspirates 178 
were unremarkable regarding cell-count, culture negative and 16S rDNA PCR 179 
negative. His blood inflammatory markers were unremarkable as well. He did not 180 
complain of any systemic symptoms and the knee X-ray did not detect any signs of 181 
loosening. After 24 months, he was discharged from the clinic with advice to be re-182 
referred in case of any problems. 183 
Personal history identified garden work and outdoor walks in tularemia endemic area 184 
as the only risk factors for zoonotic infections. Given the abdominal symptoms, 185 
intestinal form of tularemia was suspected to be the port of entry into the bloodstream 186 
and secondary spread to the knee. 187 
Operating room and laboratory staff involved in handling of the first aspirate and 188 
culture positive agar plates were offered prophylactic course of doxycycline (n=7). 189 
None of them developed any clinical symptoms of tularemia.  190 
 191 
Retrospective case findings 192 
Two other PJI cases (2, 3) and one osteomyelitis case (4) but without a joint 193 
prosthesis were found in literature. Clinical and microbiological characteristics of all 194 
four PJIs are summarized in Table 1. Three out of four PJI cases due to Francisella 195 
tularensis presented in knee arthroplasty. All were detected by positive 196 
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microbiological cultures and confirmed by positive serology, three with confirmation 197 
result by molecular-genetic methods, and one with additional acute inflammation in 198 
histopathology as an indirect sign. All were successfully treated, two cases with 199 
exchange of the prosthesis, one with debridement and retention, and one with 200 
repeated aspiration of the synovial fluid only. Antibiotic treatment was given between 201 
3 weeks and 12 months using either ciprofloxacin with or without rifampin or 202 
doxycycline with or without gentamicin. 203 
Microbiological database research 204 
Zurich. In 12 PJI cases with available F. tularensis serology -classified as culture-205 
negative PJIs, F. tularensis serology remained negative as found in a retrospective 206 
analysis of the microbiology database. Regarding positive growth in tissue biopsies 207 
or blood cultures, only 7 other positive F. tularensis cultures were documented in the 208 
same period in Zurich but without any association with an orthopedic infection.  209 
Ceske Budejovice Hospital. No data about tularemia serology are available from 210 
prosthetic joint infections. Between 2003 and 2015, only one positive blood culture 211 
out of 64 tularemia cases (1.6%) was detected (unpublished data, under review).  212 
  213 
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Discussion 214 
Orthopedic infections caused by F. tularensis are very rare. Next to our two PJI cases 215 
in Europe, we only found two other PJI cases, one described in Canada in 1999 (2, 216 
3) and one in the United States in 2017 (2, 3). In other zoonotic PJIs such as Listeria 217 
monocytogenes (5, 6), Coxiella burnetti (7), Pasteurella multocida (8), or Brucella 218 
species (9), there is an increase in reported orthopedic cases recently. In contrast to 219 
the other zoonotic pathogens, we have not found any diagnosed native joint 220 
arthritisand only one case of osteomyelitis –caused by direct inoculation from a cat 221 
bite after penetrative open injury in conjunction with Pasteurella infection (4). Biofilm 222 
formation in F. tularensis - as it has been documented in vitro and in the aquatic 223 
environment (10)– might be an important virulence factor in prosthetic material 224 
related infection.  225 
Three out of four PJI cases described here were localized in the knee joint. Two of 226 
them had a lesion on the lower limb, suggestive an infected tick bite (11) leading to 227 
an ulceroglandular form of tularemia. Such a skin lesion – often presenting as a non 228 
healing ulcer – may persist for several months. F. tularensis bacteria disseminate via 229 
the lymphatic system to the regional lymph nodes and other tissues (11). 230 
Alternatively, PJI could be caused by a hematogenous spread of F. tularensis in 231 
transient bacteremia or introduced in a previously damaged tissue via migrating 232 
granulocytes or macrophages using a Trojan horse mechanism. All four cases had 233 
some type of previous inflammation in the affected joint arthroplasty so that we 234 
question the possibility of migration of macrophages into the joint for reason other 235 
than tularemia. Those macrophages, attracted to a minor injury in the prosthetic joint, 236 
may have incidentally brought in F. tularensis in their vacuolae (12, 13) and the 237 
infection had flared up after apoptosis. Due to the fact that two out of four patients 238 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
P11 
 
were hunters, transmission route could also be through exposure to blood or body 239 
fluid with contaminated meat (11). In Germany, between 2002 and 2016, 10 240 
outbreaks of tularemia were associated with contact to wild animals in the context of 241 
hunting (14).  242 
 243 
In all four PJI cases, diagnosis was made by culture-based methods in part with 244 
longer incubation times than expected in other pathogens more commonly isolated in 245 
PJI (1). In the Swiss case, diagnosis would be missed if cultures were stopped at day 246 
10. It can be hypothesized that other tularemia cases may have been missed due to 247 
short cultivation time, difficulty to grow, and categorized as „culture-negative“ PJI” 248 
cases (15). Some of them may have resolved spontaneously, while others might 249 
have been inadvertently rightly treated with ciprofloxacin, used in some centers as a 250 
part of empirical therapy for culture negative PJIs.  251 
The low numbers of positive F. tularensis cultures or serology both in the 252 
microbiological laboratory of Zurich and Ceske Budejovice illustrates the rare event of 253 
F. tularensis in general. Large case series of F. tularensis infections reported 14% 254 
(149/1034 cases, Turkey tularemia cohort) (16) and 20.8% positive cultures (21/101 255 
cases, French cohort 2006 - 2010) (17). None of these cohorts, though, reported 256 
native or prosthetic joint or bone infections. In general, majority of clinical tularemia 257 
cases are diagnosed by antibody test and only minority by culture. The low sensitivity 258 
of the culture-based methods might be due to the current practice in many 259 
microbiology laboratories where less than 7 incubation days are standard or only 260 
anaerobic cultures respectively thioglycolate enrichment broths are kept for ten or 261 
more days.  262 
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The fact that all four so far reported tularemia PJI cases have been diagnosed by 263 
positive culture may signify that this is only a tip of the iceberg and in reality, there 264 
are more cases undiagnosed. However, no zoonotic pathogens as potential PJI 265 
pathogens to be searched for are mentioned in major guidelines (18-21).  266 
Antibiotic treatment in our four cases was given between 3 weeks and 12 months 267 
with either ciprofloxacin/rifampin or with doxycycline alone or in combination with 268 
gentamicin. Antibiotics susceptibility has not altered over years and doxycycline, 269 
aminoglycosides, and fluoroquinolones alone or in combination are mainstay of 270 
therapy (22). There is only limited data on in vitro antibiotic susceptibility of 271 
F. tularensis; however, no major changes in susceptibility rates have been reported. 272 
Duration of antibiotic therapy of more common manifestations of tularemia usually 273 
does not exceed 3 weeks, however, there have been case reports of prolonged 274 
clinical course of tularemia with the need of repeated antibiotic therapy (14). In all 275 
four reported cases of tularemia PJI, the antibiotic therapy was prolonged or 276 
repeated, and two of the cases appeared not to respond to initial course of 277 
antibiotics.  278 
There is also a significant public health and occupational health issue in case that F. 279 
tularensis is cultured in a routine bench in microbiological laboratory from 280 
unsuspecting sample. Every institution having different approach, all contacts were 281 
offered prophylactic doxycycline without seroconversion testing (Czech case), while 282 
only observation for seroconversion was performed in the other (Swiss case, 283 
described in (23)).  284 
 285 
In summary, F. tularensis is capable to cause prosthetic joint infections as shown in 286 
this article but it is a rarely detected pathogen in this setting. Culture positive PJIs 287 
begin to be more reported in recent years, probably due to increasing numbers of 288 
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implanted arthroplasties and aging population (24), along with awareness of 289 
prolonged incubation time (25, 26) in initially culture negative PJIs, and a more active 290 
lifestyle including outdoor activities of people with joint replacements. Since F. 291 
tularensis is a fastidious growing organism, we hypothesize that multiple cases may 292 
have been missed and recommend to consider tularemia together with other zoonotic 293 
pathogens in culture negative PJIs with a positive histology or significantly elevated 294 
leucocytes in the synovial fluid. For that, we suggest to prolong cultivation time up to 295 
14 days including aerobic cultures, and perform specific PCRs along with additional 296 
serological tests for zoonotic infections including F. tularensis in culture-negative 297 
PJIs. While advancements in the molecular biology techniques, such as new 298 
generation sequencing (19, 27), may refine the proportion of PJI without known 299 
pathogen, clinicians should consider both travel-related and endemic zoonotic 300 
infections in cases of true culture and PCR negative PJI and request specific 301 
antibody tests as an additional diagnostic step after blood and joint/tissue sampling 302 
for pathogens appropriate for their given geography and patients travel history. 303 
 304 
Funding: no funding. SA is consultant at Medacta SA Switzerland, otherwise no 305 
conflicts of interest.  306 
Acknowledgments. We acknowledge Dr CL Cooper and Dr H Rawal for their 307 
willingness to provide additional details of their reported cases and Dr. V. Egli for 308 
updated follow-up data of the Zurich case. 309 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
P14 
 
References 310 
1. Tande AJ, Patel R. 2014. Prosthetic joint infection. Clin Microbiol Rev 27:302-311 
45. 312 
2. Cooper CL, Van Caeseele P, Canvin J, Nicolle LE. 1999. Chronic prosthetic 313 
device infection with Francisella tularensis. Clin Infect Dis 29:1589-91. 314 
3. Rawal H, Patel A, Moran M. 2017. Unusual case of prosthetic joint infection 315 
caused by Francisella tularensis. BMJ Case Rep 2017. 316 
4. Yuen JC, Malotky MV. 2011. Francisella tularensis osteomyelitis of the hand 317 
following a cat bite: a case of clinical suspicion. Plast Reconstr Surg 128:37e-318 
9e. 319 
5. Bader G, Al-Tarawneh M, Myers J. 2016. Review of Prosthetic Joint Infection 320 
from Listeria monocytogenes. Surg Infect (Larchmt) 17:739-744. 321 
6. Charlier C, Leclercq A, Cazenave B, Desplaces N, Travier L, Cantinelli T, 322 
Lortholary O, Goulet V, Le Monnier A, Lecuit M, Infect LMJB. 2012. Listeria 323 
monocytogenes-Associated Joint and Bone Infections: A Study of 43 324 
Consecutive Cases. Clinical Infectious Diseases 54:240-248. 325 
7. Million M, Bellevegue L, Labussiere AS, Dekel M, Ferry T, Deroche P, 326 
Socolovschi C, Cammilleri S, Raoult D. 2014. Culture-negative prosthetic joint 327 
arthritis related to Coxiella burnetii. Am J Med 127:786 e7-786 e10. 328 
8. Honnorat E, Seng P, Savini H, Pinelli PO, Simon F, Stein A. 2016. Prosthetic 329 
joint infection caused by Pasteurella multocida: a case series and review of 330 
literature. BMC Infect Dis 16:435. 331 
9. Lewis JM, Folb J, Kalra S, Squire SB, Taegtmeyer M, Beeching NJ. 2016. 332 
Brucella melitensis prosthetic joint infection in a traveller returning to the UK 333 
from Thailand: Case report and review of the literature. Travel Med Infect Dis 334 
14:444-450. 335 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
P15 
 
10. van Hoek ML. 2013. Biofilms: an advancement in our understanding of 336 
Francisella species. Virulence 4:833-46. 337 
11. Ellis J, Oyston PC, Green M, Titball RW. 2002. Tularemia. Clin Microbiol Rev 338 
15:631-46. 339 
12. Ozanic M, Marecic V, Abu Kwaik Y, Santic M. 2015. The Divergent 340 
Intracellular Lifestyle of Francisella tularensis in Evolutionarily Distinct Host 341 
Cells. PLoS Pathog 11:e1005208. 342 
13. Brock SR, Parmely MJ. 2017. Complement C3 as a Prompt for Human 343 
Macrophage Death during Infection with Francisella tularensis Strain SCHU 344 
S4. Infect Immun 85. 345 
14. Faber M, Heuner K, Jacob D, Grunow R. 2018. Tularemia in Germany-A Re-346 
emerging Zoonosis. Front Cell Infect Microbiol 8:40. 347 
15. Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, 348 
Gullerud R, Osmon DR. 2007. Culture-negative prosthetic joint infection. Clin 349 
Infect Dis 45:1113-9. 350 
16. Erdem H, Ozturk-Engin D, Yesilyurt M, Karabay O, Elaldi N, Celebi G, 351 
Korkmaz N, Guven T, Sumer S, Tulek N, Ural O, Yilmaz G, Erdinc S, Nayman-352 
Alpat S, Sehmen E, Kader C, Sari N, Engin A, Cicek-Senturk G, Ertem-Tuncer 353 
G, Gulen G, Duygu F, Ogutlu A, Ayaslioglu E, Karadenizli A, Meric M, Ulug M, 354 
Ataman-Hatipoglu C, Sirmatel F, Cesur S, Comoglu S, Kadanali A, Karakas A, 355 
Asan A, Gonen I, Kurtoglu-Gul Y, Altin N, Ozkanli S, Yilmaz-Karadag F, 356 
Cabalak M, Gencer S, Umut Pekok A, Yildirim D, Seyman D, Teker B, Yilmaz 357 
H, Yasar K, Inanc Balkan I, Turan H, Uguz M, et al. 2014. Evaluation of 358 
tularaemia courses: a multicentre study from Turkey. Clin Microbiol Infect 359 
20:O1042-51. 360 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
P16 
 
17. Maurin M, Pelloux I, Brion JP, Del Bano JN, Picard A. 2011. Human tularemia 361 
in France, 2006-2010. Clin Infect Dis 53:e133-41. 362 
18. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, 363 
Rao N, Hanssen A, Wilson WR, America IDSo. 2013. Diagnosis and 364 
management of prosthetic joint infection: clinical practice guidelines by the 365 
Infectious Diseases Society of America. Clin Infect Dis 56:e1-e25. 366 
19. Goswami K, Parvizi J, Maxwell Courtney P. 2018. Current Recommendations 367 
for the Diagnosis of Acute and Chronic PJI for Hip and Knee-Cell Counts, 368 
Alpha-Defensin, Leukocyte Esterase, Next-generation Sequencing. Curr Rev 369 
Musculoskelet Med 11:428-438. 370 
20. Sendi P, Zimmerli W. 2012. Diagnosis of periprosthetic joint infections in 371 
clinical practice. Int J Artif Organs 35:913-22. 372 
21. Muhlhofer HM, Pohlig F, Kanz KG, Lenze U, Lenze F, Toepfer A, Kelch S, 373 
Harrasser N, von Eisenhart-Rothe R, Schauwecker J. 2017. Prosthetic joint 374 
infection development of an evidence-based diagnostic algorithm. Eur J Med 375 
Res 22:8. 376 
22. Tomaso H, Hotzel H, Otto P, Myrtennas K, Forsman M. 2017. Antibiotic 377 
susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from 378 
Germany. J Antimicrob Chemother 72:2539-2543. 379 
23. Keller PM, Bruderer V, Muller F. 2016. Restricted Identification of Clinical 380 
Pathogens Categorized as Biothreats by Matrix-Assisted Laser Desorption 381 
Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol 54:816. 382 
24. Del Pozo JL, Patel R. 2009. Clinical practice. Infection associated with 383 
prosthetic joints. N Engl J Med 361:787-94. 384 
25. Bossard DA, Ledergerber B, Zingg PO, Gerber C, Zinkernagel AS, Zbinden R, 385 
Achermann Y. 2016. Optimal Length of Cultivation Time for Isolation of 386 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
P17 
 
Propionibacterium acnes in Suspected Bone and Joint Infections Is More than 387 
7 Days. J Clin Microbiol 54:3043-3049. 388 
26. Schafer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. 2008. 389 
Prolonged bacterial culture to identify late periprosthetic joint infection: a 390 
promising strategy. Clin Infect Dis 47:1403-9. 391 
27. Tarabichi M, Shohat N, Goswami K, Alvand A, Silibovsky R, Belden K, Parvizi 392 
J. 2018. Diagnosis of Periprosthetic Joint Infection: The Potential of Next-393 
Generation Sequencing. J Bone Joint Surg Am 100:147-154. 394 
395 
 o
n
 July 5, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
V02_Tularemia PJI JCM00339-19 20.05.19 
 
Tables and Figures 396 
Figure legends 397 
Figure 1. Histopathology of the knee PJI case in Zurich with acute inflammation with dominance of neutrophils at time of implant 398 
removal. In A: Tunica synovialis with florid granulocytic inflammation. Triangles indicate small clusters of neutrophils (HE staining, 399 
200x). In B: Foreign body reaction to prosthetic material with diffuse histiocytic infiltration and multinucleated giant cells, indicated by 400 
asterisks (HE staining, 200x)  401 
 402 
 403 
  404 
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Tables 405 
Table 1. Clinical characteristics of 4 patients with Francisella tularensis periprosthetic joint infections (PJIs). 406 
Case no., country 1 (23), Switzerland 2, Czech Republic 3 (2), Ontario, Canada 4 (3), Illinois, USA 
Age (years), gender 84, female 84, male 68, male 77, male 
Time of presentation 2016 2016 1999 2017 
Affected joint Knee Knee Knee Hip 
Immunosuppression No No Rheumatoid arthritis 
(methotrexate) 
No 
Previous infection of the affected joint No E. coli PJI infection 8 
years prior, cured with 
DAIR 
Enterococcus faecalis 
early infection, cured 
No, but recent (7 
days) revision THR 
due to pain and 
limited range of 
movement 
Potential source of acquisition Housing of rabbits in 
next-door house 
(infected dust?) 
No apparent exposure, 
but abdominal 
symptoms prior to the 
joint effusion 
suggestive of intestinal 
tularemia  
Hunter, tick bite 6 
months before 
arthroplasty 
Hunter, no tick bite 
Time to diagnosis after previous 
surgical intervention/revision 
12 years 8 years 6 months 25 years  
Bullous lesion on the 
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Case no., country 1 (23), Switzerland 2, Czech Republic 3 (2), Ontario, Canada 4 (3), Illinois, USA 
shin 1 year before 
onset of symptoms 
Clinical findings Erythema, joint pain, 
no fever 
Fever, abdominal pain, 
confusion, painful 
knee effusion 
Discharge from the 
joint, no fever 
Fever, joint pain 
 
CRP (mg/L) 81 98 NA 16 
ESR (mm/h) 69 NA 47 96 
Microbiology     
 Positive cultures Yes (6 out of 7), 
thioglycolate broth 
Sonication negative 
Yes, Columbia 5% 
sheep blood agar 
Yes, chocolate agar Yes, 2 joint aspirates, 
Vitek cultures 
 Type of sample 
 
Tissue cultures 
 
Joint aspiration Joint aspiration 
 
Joint aspiration 
 Days of cultivation until growth 12 days (blind 
subculture) 
4 days 3 days 
 
7 days 
 Molecular method 16S rDNA and 
specific PCR negative 
in tissue sample 
16S rDNA sequencing 
of growing pathogen 
positive 
16S rDNA PCR and 
sequencing of the 
colonies grown on 
agar 
Culture Sequencing:  
F. tularansis tularensis 
Biovar type B 
NA 
Serology for F. tularensis IgM 232.6 U/ml (N < 1:80 titer 1:320 titer Results reported as 
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Case no., country 1 (23), Switzerland 2, Czech Republic 3 (2), Ontario, Canada 4 (3), Illinois, USA 
10U/ml) 
IgG 126.4 U/ml (N < 
10U/ml) 
(microagglutination) (microagglutination) positive from the lab, 
without stating any 
titers 
Finding in histopathology Acute inflammation, 
wear of prosthesis 
NA NA NA 
Surgical treatment 2-stage revision joint 
replacement 
Repeated aspiration 
only 
2-stage revision joint 
replacement 
DAIR 
Antibiotic treatment 6 weeks 
Doxycycline 100 mg 
twice daily 
3 and 3 weeks 
Doxycycline 20 days 
100 mg bd + 
gentamicin 10 days 
240 mg od, followed 
by 20 days of 
ciprofloxacin 500 mg 
bd 
6 months 
Ciprofloxacin/ rifampicin 
(unknown dose) 
(initially no response to 
ciprofloxacin in 
monotherapy) 
12 months 
Doxycycline 100mg 
twice daily 
Cure (time to follow-up) 2 years 2 years More than 6 months 1 year 
Number of health-care workers who 
took post-exposure antibiotic 
prophylaxis 
0 7 Unknown Unknown 
NA, not available; Rx, treatment, DAIR – debridement, antibiotics, implant retention, CRP – C reactive protein, ESR – erythrocyte sedimentation 407 
rate 408 
Data not containted in the original case studies were obtained by email communication from the corresponding authors of the cited papers 409 
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